BillionToOne Alternatives & Competitors
12 companies similar to BillionToOne — We push the boundaries of molecular diagnostics through quantitative technologie...
NBE-Therapeutics AG
Next generation antibody drug conjugates
Basel, Switzerland
CureVac
We fight for human health - we are the RNA people
Tubingen, Germany
Engine Biosciences
Deciphering Biological Complexity to Unleash Many Impactful Medicines
Singapore, Singapore
MEGI Health
AI-powered care that starts in pregnancy and supports women’s hearts for life.
London, United Kingdom
Track all BillionToOne competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Juno Diagnostics
Prenatal Testing Reimagined
San Diego, United States
MultivisionDx
Transforming cancer diagnostics
Helsinki, Finland
ARTIDIS
A clinical stage company developing the first nanotechnology platform for rapid diagnostic...
Basel, Switzerland
InterVenn Biosciences
We are a life science company decoding the glycoproteome to power personalized, predictive...
South San Francisco, Unit...
ABK Biomedical Inc.
Improving treatment options for patients with hypervascular tumors
Canada
Onc.AI
Non-invasive radiomic-based biomarkers for clinical decision support
San Carlos, United States
Sapience Therapeutics, Inc.
Changing the Tide to Achieve the Unachievable
Tarrytown, United States
Imvax, Inc.
Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-deriv...
Philadelphia, United Stat...
About BillionToOne
We push the boundaries of molecular diagnostics through quantitative technologies.
Development and provision of advanced diagnostic tests, Quantification of disease-causing DNA fragments, Non-invasive prenatal and oncology testing solutions, Monitoring treatment response in cancer patients
Healthcare Providers, Pregnant Women, Oncologists, Medical Researchers
Molecular Diagnostics, Precision Diagnostics, DNA Quantification, Molecular Counting Technology, Disease Detection, Prenatal Testing, Single-gene Disorder Detection, Non-invasive Testing, Blood Test Innovation, Affordable Healthcare Solutions, Patent-pending Technology, Risk Reduction In Diagnostics, Biotechnology Innovation
B2B, D2C, B2D
Service Fee, Usage Based, Transaction Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches BillionToOne and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at BillionToOne on 9 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.